-+ 0.00%
-+ 0.00%
-+ 0.00%

Dong-A Pharmaceutical Q3 Operating Profit Rises 5.37% Year Over Year

PUBT·10/27/2026 02:34:33
Listen to the news
Dong-A Pharmaceutical Q3 Operating Profit Rises 5.37% Year Over Year
  • Dong-A Pharmaceutical’s third-quarter 2026 operating profit rose 5.37% year over year to KRW 35.1 billion.
  • Revenue increased 12.66% from a year earlier to KRW 431.04 billion.
  • Compared with the previous quarter, operating profit fell 9.92%, while revenue grew 4.52%.
  • Revenue for January-September 2026 reached KRW 1.19 trillion, up 12.91% year over year.
  • Operating profit for the nine months increased 13.9% to KRW 93.19 billion.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Dong-A Pharmaceutical Co. Ltd. published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20261027800177), on October 27, 2026, and is solely responsible for the information contained therein.